Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication

January 6, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that an article published December 29, 2025 in HEALTH, a bi-monthly English and Arabic healthcare magazine in the United Arab Emirates, discusses the groundbreaking results of the ongoing and independent proof-of-concept study of crofelemer in pediatric patients in the UAE with intestinal failure due to the orphan diseases short bowel syndrome (SBS-IF) and microvillus inclusion disease...

Read more

XVIVO's CEO to present at J.P. Morgan's 44th Annual Healthcare Conference in San Francisco

January 6, 2026 9:00 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announced its participation in the 44th annual J.P. Morgan Healthcare Conference in San Francisco, US, on Wednesday, January 14, 2026. Christoffer Rosenblad, CEO, was invited to deliver a formal presentation and participate in a Q&A session beginning at 4:30 p.m. PST.Rosenblad's presentation will focus on the future of the organ transplant industry and how new technologies are...

Read more

Integra Partners and HelixVM Collaborate to Redefine DME Patient Access

January 6, 2026 9:00 AM

Integra Partners has entered a strategic partnership with HelixVM, a leader in 24/7 "visit-less" asynchronous virtual care, under its Group Purchasing Organization (GPO) offer. The partnership tackles one of the biggest challenges in the durable medical equipment prosthetics, orthotics and supplies (DMEPOS) industry-getting the documentation and medical orders required to bill for services. This partnership is intended to create an integrated...

Read more

MDaudit Expands Executive Team

January 6, 2026 9:00 AM

MDaudit, an award-winning cloud-based continuous risk monitoring platform for RCM that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, announced today the expansion of its executive team as the company seeks to expand its footprint and prominence in the healthcare revenue integrity market. Nicholas Rodich joins MDaudit as Chief Commercial Officer, and Johnny Kaye as Chief Operating Officer....

Read more

Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)

January 6, 2026 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Lizette Leos, MD to Chief Scientific Officer. (Stemtech Corporation - OTCQB:STEK)Dr. Lizette Betsabe Leos Lopez, MD President & COO, John W. Meyer stated "Dr. Leos has been with Stemtech since 2017 and has significantly contributed to the science, creation and development, including education of our stemceuticals™ all-natural, plant-based,...

Read more

Mmimetika Appoints Metabolic Health Expert Karan Sarin as CEO to Lead Global Commercialization

January 6, 2026 8:05 AM

Mmimetika ApS, a biotech company developing lactate-ketone ester dietary supplements for metabolic support, today announced the appointment of Karan Sarin as Chief Executive Officer, effective January 1, 2026. The appointment comes as Mmimetika transitions from clinical validation to commercial scale, with US GRAS (Generally Recognized as Safe) compliance on track for H1 2026 and independent clinical trials demonstrating efficient raise of...

Read more

CBD Life Sciences Inc. (CBDL) Expands Into JFK Airport Through Landmark Mother Earth Juice Bar Partnership in New York

January 6, 2026 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), a fast-growing innovator in hemp-derived wellness and pain relief solutions, today announced it has secured Mother Earth Juice Bar as a new retail client for its 8000MG Hemp Pain Relief Cream, marking a strategic expansion into New York City through John F. Kennedy International Airport (JFK).Mother Earth Juice Bar operates multiple locations across New York, including a high-visibility storefront inside JFK...

Read more

Evidently and Sholder Healthcare Announce Strategic Partnership to Transform Hospital Throughput and Length of Stay

January 6, 2026 6:00 AM

Evidently, the leader in Clinical Data Intelligence, today announced a strategic partnership with Sholder Healthcare, a consultancy of nationally-recognized experts pioneering hospital care coordination process & methodology focused on reducing length of stay, readmissions, and denials. The partnership integrates Sholder Healthcare's ProActive Care Throughput (PACT) Model operational framework for hospital care coordination with Evidently's...

Read more

Rivia Mind Opens Boston Office to Address Growing Mental Health Needs

January 6, 2026 6:00 AM

Rivia Mind, a mental health practice committed to compassionate, evidence-based care, today announced the opening of its in-person office in Boston in response to growing gaps in access to mental health services across the Commonwealth. Beginning January 12, 2026, patients will be able to access face-to-face psychiatric and therapy services at the new location, complementing Rivia Mind's established virtual offerings across Massachusetts.The...

Read more

Xironetic Appoints Brandon Strong as Chief Product Officer and Chief Research Officer

January 5, 2026 11:25 PM

Xironetic, a provider of augmented reality surgical guidance technology, today announced the appointment of Brandon Strong as Chief Product Officer and Chief Research Officer."This appointment reflects Brandon's tremendous impact in refining our product and translating our technology to a broad range of users," said Dr. Christian El-Amm, Founder and Executive Chairman of Xironetic and Chief of Pediatric Plastic Surgery at Oklahoma Children's...

Read more

Black Book Research Publishes 2026 Australia Acute-Care EMR/EHR Strategic Fit Benchmark

January 5, 2026 11:00 PM

Black Book Market Research LLC today released State of Australian Healthcare IT 2026: Strategic Fit of Acute-Care EMR/EHR Platforms, a technology-forward benchmark intended to support Australian hospital and health service leadership teams as they assess digital clinical platform options across a 2026-2030 planning horizon.Based on input from 454 validated Australian stakeholders with direct EMR/EHR experience, the report evaluates 13 acute-care...

Read more

LEM Surgical Showcases the World's First "Surgical Humanoid" at CES 2026; Groundbreaking NVIDIA Physical AI Toolsets to Drive Dynamis Robotic Surgical System Development

January 5, 2026 6:00 PM

LAS VEGAS, NV and BERN, SWITZERLAND / ACCESS Newswire / January 5, 2026 / LEM Surgical, a leader in next-generation hard tissue robotics, today announced its participation in the 2026 Consumer Electronics Show (CES). At this year's event, LEM is highlighting the commercial success of the Dynamis Robotic Surgical System, the first surgical humanoid optimally adapted to the unique demands of the operating room, while unveiling a strategic roadmap...

Read more

Black Book Research Publishes 2026 Methodology and Governance Statement for Healthcare IT Vendor Rankings

January 5, 2026 5:30 PM

Black Book Research today issued its 2026 Methodology and Governance Statement, detailing the research architecture, controls, and validation processes used to produce and maintain its annual Healthcare IT vendor rankings. The statement reaffirms Black Book's operating standard for ethical, longitudinal market research: comparative findings must be grounded in verified user experience, governed transparently, and structurally protected from...

Read more

Go North Hemp Enters 2026 Following Record 2025 Performance as Hemp Industry Shifts to Infrastructure

January 5, 2026 1:50 PM

Go North Hemp is positioned to close December 2025 as either its strongest or second-strongest month in company history, capping a year defined by disciplined execution as the hemp industry underwent a fundamental structural shift. The momentum comes as the broader hemp sector exits what Go North Hemp leadership describes as its adolescent phase, a transition that became unmistakably clear at MJ BizCon 2025, where strategic coordination...

Read more

Medical Care Technologies Inc. (OTC Pink: MDCE) Announces Completion of Readiness Testing for AI-Powered Skin Lesion Pre-Screening Mobile Application

January 5, 2026 11:15 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) announced today that the Company has successfully completed its internal readiness testing phase for its forthcoming AI-powered mobile application designed for skin lesion pre-screening and risk-awareness. The mobile application is scheduled for public release later this year.The application utilizes AI-driven visual analysis tools to help users identify skin features that may warrant clinical...

Read more

DirectTrust(R) Announces 2026 Accreditation Criteria Versions for All Accreditation Programs

January 5, 2026 9:00 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, announced the release of new versions of program criteria for its 28 accreditation programs starting January 1, 2026.A key update for 2026 is the introduction of the new Artificial Intelligence (AI) Program, currently in Beta, with multiple organizations participating...

Read more

Ensysce Biosciences Issues Annual Shareholder Letter

January 5, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today issued its 2025 annual letter to shareholders from Chief Executive Officer, Dr. Lynn Kirkpatrick.Dear Fellow Shareholders,2025 was a year of meaningful execution and strategic advancement for Ensysce. I would like to thank...

Read more

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models

January 5, 2026 8:00 AM

Telomir Pharmaceuticals (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of diseases, today announced results from a completed efficacy study evaluating Telomir-1 (Zn-Telomir) in zebrafish tumor xenograft animal models of triple-negative breast cancer (TNBC). The study was conducted in collaboration with BioReperia using its...

Read more

Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

January 5, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 years and older. The Company has filed for marketing authorization with the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada, and the Therapeutic Goods Administration (TGA) in Australia."We are proud to announce these filings for the use of our...

Read more

Neurodivergent Empowerment Institute Issues Special Call for Touchable, Sensory-Friendly Art

January 5, 2026 7:00 AM

The Neurodivergent Empowerment Institute (NEI), part of the Bionic Bloom Wellness Collective family of wellness centers, is issuing a special call for artists creating touchable, interactive, and sensory-friendly artwork for upcoming installations within its therapeutic and educational spaces.As a member of the Bionic Bloom collection, NEI is grounded in an integrative, empowerment-based philosophy that blends mental health care, somatic...

Read more